Abnormal findings in specimens from female genital organs
Notes: Positive culture findings in specimens from female genital organs ; Inadequate sample of cytologic smear of cervix ; Abnormal cervical cytology NOS ; Abnormal Papanicolaou smear of cervix NOS ; Abnormal thin preparation smear of cervix NOS ; Atypical endocervial cells of cervix NOS ; Atypical endometrial cells of cervix NOS ; Atypical glandular cells of cervix NOS ; Inadequate sample of cytologic smear of vagina ; Abnormal Papanicolaou smear of vagina NOS ; Abnormal thin preparation smear of vagina NOS ; Abnormal vaginal cytology NOS ; Atypical endocervical cells of vagina NOS ; Atypical endometrial cells of vagina NOS ; Atypical glandular cells of vagina NOS ; Abnormal cytological findings in specimens from female genital organs NOS ; Abnormal chromosomal findings in specimens from female genital organs ; code to identify acquired absence of uterus and cervix, if applicable (Z90.71-) ; code for associated human papillomavirus (B97.7) ; colonization status (Z22.-) ; abnormal cytological findings in specimens from other female genital organs (R87.69) ; abnormal cytological findings in specimens from vagina (R87.62-) ; carcinoma in situ of cervix uteri (histologically confirmed) (D06.-) ; cervical intraepithelial neoplasia I [CIN I] (N87.0) ; cervical intraepithelial neoplasia II [CIN II] (N87.1) ; cervical intraepithelial neoplasia III [CIN III] (D06.-) ; dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-) ; severe dysplasia of cervix uteri (histologically confirmed) (D06.-) ; abnormal cytological findings in specimens from cervix uteri (R87.61-) ; abnormal cytological findings in specimens from other female genital organs (R87.69) ; carcinoma in situ of vagina (histologically confirmed) (D07.2) ; vaginal intraepithelial neoplasia I [VAIN I] (N89.0) ; vaginal intraepithelial neoplasia II [VAIN II] (N89.1) ; vaginal intraepithelial neoplasia III [VAIN III] (D07.2) ; dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-) ; severe dysplasia of vagina (histologically confirmed) (D07.2) ; dysplasia of vulva (histologically confirmed) (N90.0-N90.3) ; carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3) ; cervical intraepithelial neoplasia I [CIN I] (N87.0) ; cervical intraepithelial neoplasia II [CIN II] (N87.1) ; cervical intraepithelial neoplasia III [CIN III] (D06.-) ; dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-) ; dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-) ; vaginal intraepithelial neoplasia I [VAIN I] (N89.0) ; vaginal intraepithelial neoplasia II [VAIN II] (N89.1) ; vaginal intraepithelial neoplasia III [VAIN III] (D07.2) ; severe dysplasia of cervix uteri (histologically confirmed) (D06.-) ; severe dysplasia of vagina (histologically confirmed) (D07.2) ; anogenital warts due to human papillomavirus (HPV) (A63.0) ; condyloma acuminatum (A63.0) ; cervical high risk human papillomavirus (HPV) DNA test positive (R87.810) ; cervical low risk human papillomavirus (HPV) DNA test positive (R87.820) ; vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811) ; vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)